Global Newborn Screening Market Expected to Reach $1.1 Billion by 2032, Driven by Advances in Technology and Government Initiatives
The market for newborn screening on a global scale is anticipated to reach US$ 520 million in FY 2022, up from US$ 480 million in 2021. The industry experienced a Y-o-Y growth of 8.3% over the previous year. The newborn screening market is anticipated to expand between 2022 and 2032 at a CAGR of 7.8%, reaching a value of US$ 1.1 billion by the end of that year. The newborn screening market refers to the testing and analysis of blood samples taken from newborn infants to identify any potential genetic disorders or other medical conditions that could require early intervention. Newborn screening tests are typically performed within the first few days of a baby’s life and are designed to identify conditions that may not be apparent at birth but could have long-term health consequences if left untreated
The global newborn screening market is expected to grow significantly in the coming years, driven by factors such as increasing awareness about the benefits of early diagnosis and treatment, advancements in technology that have made screening tests more accurate and efficient, and a growing number of government initiatives aimed at expanding access to newborn screening programs.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=6323
Key Takeaways
- In terms of product, newborn screening consumables demand is poised to expand at nearly 8% CAGR through 2031
- Based on technology, immunoassay-and enzymatic assay, collectively, are expected to lead the segment, exhibiting a CAGR of over 7% during the forecast period
- In terms of test, dry blood spot newborn screening is poised to acquire precedence, registering growth at 9% CAGR
- The U.S. newborn screening market is likely to generate significant opportunities for the market players, expanding at a CAGR of 5% over the forecast period
- Increasing government initiatives to curb the infant mortality rates across India will bolster the demand of newborn screening, generating around 30% of revenue
- China is anticipated to lead the East Asia market, accounting for over 50% of market share owing to the increasing cases of congenital hypothyroidism in the region
Competitive Landscape
Key players are focusing on expansion of their product portfolios through acquisition of existing players and forming alliance with top companies. Manufacturers are also reliant on strategic partnerships and mergers to expand their global reach and maintain their position in the industry.
- In September 2020, PerkinElmer received approval for its new launch of CE-IVD approval for EONIS screening assay used to screen spinal muscular atrophy, X-linked agammaglobulinemia, and severe combined immunodeficiency among newborns.
- In February 2021, LifeCell, India’s largest stem cell back announced relief fund and special offers to the parents for the screening of newborns. Baby shield Newborn Screening combines biochemical testing of 100+ metabolic and genetic conditions with confirmatory genetic testing.
- In December 2019, PerkinElmer received the U.S. Food and Drugs Administration approval for GSP Neonatal Creatine Kinase-MM kit for newborn screening affected by Duchenne muscular dystrophy.
Prominent newborn screening manufacturers listed in Fact.MR’s report are listed below:
- Bio-Rad Laboratories
- Danaher Corporation
- Medtronic Plc.
- Chromsystems Instruments & Chemicals GmbH
- Trivitron Healthcare
- Baebies
- Masimo Corporation
- Natus Medical Inc.
- RECIPE Chemicals + Instruments GmbH
Get Customization on this Report for Specific Research Solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=6323
Regional Analysis For Newborn Screening Market
The newborn screening market can be analyzed regionally to identify trends and opportunities in different parts of the world. Here is a brief overview of the newborn screening market by region:
- North America: North America is the largest market for newborn screening, with the United States being the largest contributor to the market. The market is driven by factors such as high healthcare expenditure, a well-established healthcare infrastructure, and a high prevalence of genetic disorders in the population.
- Europe: Europe is the second-largest market for newborn screening, with countries such as the United Kingdom, Germany, and France being major contributors to the market. The market is driven by factors such as increasing awareness about the benefits of early diagnosis and treatment, favorable government policies, and the availability of advanced screening technologies.
- Asia-Pacific: The Asia-Pacific region is expected to be the fastest-growing market for newborn screening, driven by factors such as a large population base, increasing healthcare expenditure, and growing awareness about the benefits of early diagnosis and treatment. Countries such as China and India are expected to be major contributors to the market.
- Latin America: The Latin America market for newborn screening is growing, driven by factors such as increasing healthcare expenditure, favorable government policies, and growing awareness about the benefits of early diagnosis and treatment.
- Middle East & Africa: The Middle East & Africa market for newborn screening is relatively small, but it is expected to grow in the coming years as healthcare infrastructure improves and awareness about the benefits of early diagnosis and treatment increases.
For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/6323
Key Questions Covered in the Report
- What are the growth prospects for newborn screening products manufacturers during the forecast period?
- Which are the prominent manufacturers operating in the newborn screening market?
- Which region will be the most lucrative for newborn screening markets?
- Which technology of newborn screening will be the most preferred in the upcoming decade?
- Which test type of newborn screening market will have the highest market share during the forecast period?
- What are the key challenges faced by newborn screening manufacturers?
- What is the impact of Covid-19 on newborn screening market?
Overall, the newborn screening market is expected to continue to grow as more countries around the world implement screening programs and as new technologies emerge that improve the accuracy and efficiency of screening tests.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Xherald
